Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2015 10:18 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares

TEL-AVIV, Israel, Feb. 13, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late...
June 30, 2014 06:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Acquires Phase II Oncology Drug MESUPRON(R) From WILEX AG

RedHill expands its late clinical-stage gastrointestinal-focused pipeline with MESUPRON®, an oncology drug targeting gastrointestinal and other solid tumor cancers licensed from Wilex...